Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure is a research paper published in European Journal of Heart Failure (2023). On theSindex it has a DataRank of 1.0. It has been cited 40 times, with 36 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0.467
From 22 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 36 citers.
National Institutes of Health
Grant: P01HL147823
National Institutes of Health
Grant: R01HL103866
National Institutes of Health
Grant: R01HL167831-01A1
Fondation Leducq
Grant: 17CVD01
National Institutes of Health
Grant: R01HL167831‐01A1
NHLBI NIH HHS
Grant: R01 HL167831
NHLBI NIH HHS
Grant: R01 HL135920
National Institutes of Health
Grant: 5R01HL103866-03
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
National Institutes of Health
Grant: 1R01HL167831-01A1
Gut microbial dietary phenylalanine metabolism and heart failure
National Institutes of Health
Grant: 5P01HL147823-03
Gut Microbiota and Cardiometabolic Diseases
FWCI
3.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals